Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Theravance Biopharma US Inc (TBPH)

  • Event
  • July 14, 2022, 01:57 UTC
  • 14
  • 1 comments

(99% Neutral) THERAVANCE BIOPHARMA, INC. (TBPH) Announces Business Combination

Comment Full text

Innoviva Inc (INVA)

  • Event
  • July 13, 2022, 21:27 UTC
  • 13
  • 1 comments

(99% Neutral) INNOVIVA, INC. (INVA) Announces Business Combination

Comment Full text

Ascendis Pharma (ASND)

  • Event
  • July 13, 2022, 21:04 UTC
  • 12
  • 1 comments

(99% Neutral) Ascendis Pharma (ASND) Announces Executive Changes (Form 6-K)

Comment Full text

Theravance Biopharma US Inc (TBPH)

  • Event
  • July 13, 2022, 20:55 UTC
  • 13
  • 1 comments

(19% Negative) THERAVANCE BIOPHARMA, INC. (TBPH) Announces Delay in units Trials for Potential Total Value ·Over $1 Due to Pandemic-Related Challenges, Regulatory Process

Comment Full text

Royalty Pharma (RPRX)

  • Event
  • July 13, 2022, 20:34 UTC
  • 13
  • 1 comments

(55% Positive) Royalty Pharma plc (RPRX) Announces Business Combination

Comment Full text

BELLUS Health Inc (the company became a subdivision of the company GSK (NYSE: GSK)) (BLU)

  • Event
  • July 13, 2022, 20:25 UTC
  • 10
  • 1 comments

(99% Neutral) BELLUS Health Inc (the company became a subdivision of the company GSK (NYSE: GSK)) (BLU) Files Form 6-K

Comment Full text

Verrica Pharmaceuticals (VRCA)

  • Event
  • July 13, 2022, 20:16 UTC
  • 13
  • 1 comments

(99% Neutral) Verrica Pharmaceuticals Inc. (VRCA) Provides Business Update

Comment Full text

Precigen Inc (PGEN)

  • Event
  • July 13, 2022, 20:14 UTC
  • 13
  • 1 comments

(99% Neutral) Precigen, Inc. (PGEN) Announces Business Combination

Comment Full text

CytomX Therapeutics Inc (CTMX)

  • Event
  • July 13, 2022, 20:10 UTC
  • 13
  • 1 comments

(70% Positive) CYTOMX THERAPEUTICS, INC. (CTMX) Announces New Board Appointment

Comment Full text

BELLUS Health Inc (the company became a subdivision of the company GSK (NYSE: GSK)) (BLU)

  • Event
  • July 13, 2022, 20:10 UTC
  • 10
  • 1 comments

(99% Neutral) BELLUS Health Inc (the company became a subdivision of the company GSK (NYSE: GSK)) (BLU) Files Form 6-K

Comment Full text
  • Previous
  • 159
  • 160
  • 161
  • 162
  • 163
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189155)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124508)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin